BusinessAsklepios BioPharmaceutical, Inc. Announces Former Portfolio Company’s Preclinical Asset for Duchenne Muscular Dystrophy Has Advanced into the ClinicBy Nasdaq OMXApr 25, 2018, 12:05 PM UTC
BusinessNew Patient-Centered Program Launched for New York Primary Care PracticesBy Nasdaq OMXApr 3, 2018, 9:14 PM UTC
